Comment policy

Commenting

We want to make sure LabTalk provides a good experience for all visitors. Therefore, we want to keep the content focused on the specific topics being addressed. Comments that don’t directly relate to AstraZeneca or the topics currently being discussed, or comments or questions about specific products (whether or not AstraZeneca products) or ongoing legal or regulatory matters may not be published or may be removed. If you have questions about AstraZeneca products, please get in touch. We reserve the right to not publish or to remove comments that are obscene, inflammatory, disrespectful, contain profanity, or that we deem are otherwise inappropriate. We may not publish or may remove comments that could be misleading or confusing, or thinly disguised sales pitches for other products or services. Additionally, we may not publish or may remove a link contained in your comment if it does not meet the criteria. However, LabTalk is about engagement so if we feel that a response is warranted, we will do our best to respond to your comments within three working days.

Follow-Up

We want to hear your stories, viewpoints and opinions – even if they are contradictory to ours. We do require that you include an email address so we may follow up with you if needed. Your email address will only be used to contact you regarding your posting. Please refer to AstraZeneca’s Privacy Statement for more information.

Side Effects

In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product.

- In the United States, adverse events/side effects can be reported to FDA by visiting www.FDA.gov/medwatch or by calling FDA at 1-800-FDA-1088. Alternatively, you may report this directly to AstraZeneca (in the US only) by calling 1-800-236-9933.

- Outside the United States, countries worldwide may have specific processes in place to handle reports of adverse events. To report an adverse event, ask your health care provider for more information or contact your local health authority

Other Information

The content on LabTalk is for information purposes only and is not intended to be a substitute for professional medical advice. The comments on LabTalk come from the public and do not necessarily reflect the views of AstraZeneca, and AstraZeneca does not endorse or approve the contents of such comments.

Any communications or information submitted through LabTalk, including comments, questions, data, ideas or know-how shall be deemed to be non-confidential and shall become the property of AstraZeneca, without compensation to the provider of such submissions. AstraZeneca shall have no obligation of any kind with respect to such information and may reproduce, publish, disclose, and distribute to others all or any part of such information, without limitation, for any purpose whatsoever. AstraZeneca shall be free to use any ideas, concepts, know-how, techniques or inventions contained therein for any purpose, including but not limited to developing, manufacturing and marketing products and services.

Please note, when a comment is published on LabTalk, your name will appear above it, not your username.